Over the past four decades, the Food and Drug Administration (FDA) has been approving new prescription drugs faster. That’s a great thing, since quicker approvals give terminally-ill patients faster access to potentially life-saving treatments. Of course, some critics aren’t happy, and it’s leading them to wonder if the FDA needs to slow “its drug approval roll.”
But slowing down the approval process by bolstering the bureaucracy won’t help people—it’ll kill them.
It’s already slower than it should be. Sure, the approval process has been picking up, but drug development has become increasingly leaden, thanks to changes made to the Food and Drug Act in 1962. Known as the Kefauver-Harris Amendments, the regulatory burden for researchers, developers, and manufacturers has become far too much, and what once took four years now takes roughly 14.
Read more at Free The People.
By: Lindsay Marie, Criminal Justice Policy Analyst